Bifogade filer
PDF
Kurs
-2,92%
Likviditet
6,97 MSEK
Kalender
| Tid* | ||
| 2025-10-22 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-18 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-07 | N/A | Årsstämma |
| 2025-05-07 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-02-12 | 08:00 | Bokslutskommuniké 2024 |
| 2024-10-22 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-08 | - | X-dag ordinarie utdelning BIOG B 1.90 SEK |
| 2024-05-08 | - | X-dag bonusutdelning BIOG B 5 |
| 2024-05-07 | - | Årsstämma |
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-07 | - | Bokslutskommuniké 2023 |
| 2023-10-20 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-21 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-08 | - | X-dag ordinarie utdelning BIOG B 1.45 SEK |
| 2023-05-08 | - | X-dag bonusutdelning BIOG B 1.45 |
| 2023-05-05 | - | Årsstämma |
| 2023-05-05 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-05 | - | X-dag ordinarie utdelning BIOG B 1.45 SEK |
| 2023-05-05 | - | X-dag bonusutdelning BIOG B 1.45 |
| 2023-02-03 | - | Bokslutskommuniké 2022 |
| 2022-10-21 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-22 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-18 | - | Split BIOG B 1:5 |
| 2022-05-09 | - | X-dag ordinarie utdelning BIOG B 3.63 SEK |
| 2022-05-09 | - | X-dag bonusutdelning BIOG B 11.29 |
| 2022-05-06 | - | Årsstämma |
| 2022-05-06 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-04 | - | Bokslutskommuniké 2021 |
| 2021-10-21 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-12 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-07 | - | X-dag ordinarie utdelning BIOG B 3.41 SEK |
| 2021-05-06 | - | Årsstämma |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-04 | - | Bokslutskommuniké 2020 |
| 2020-11-25 | - | Extra Bolagsstämma 2020 |
| 2020-10-23 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-13 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-08 | - | X-dag ordinarie utdelning BIOG B 3.75 SEK |
| 2020-05-07 | - | Årsstämma |
| 2020-05-07 | - | Kvartalsrapport 2020-Q1 |
| 2020-05-07 | - | X-dag ordinarie utdelning BIOG B 3.75 SEK |
| 2020-02-06 | - | Bokslutskommuniké 2019 |
| 2019-10-23 | - | Kvartalsrapport 2019-Q3 |
| 2019-05-09 | - | X-dag ordinarie utdelning BIOG B 4.05 SEK |
| 2019-05-09 | - | X-dag bonusutdelning BIOG B 5.95 |
| 2019-02-07 | - | Bokslutskommuniké 2018 |
| 2018-10-24 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-17 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-26 | - | X-dag ordinarie utdelning BIOG B 4.31 SEK |
| 2018-04-26 | - | X-dag bonusutdelning BIOG B 4.69 |
| 2018-04-25 | - | Årsstämma |
| 2018-04-25 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-08 | - | Bokslutskommuniké 2017 |
| 2017-10-25 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-18 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-04 | - | X-dag ordinarie utdelning BIOG B 3.16 SEK |
| 2017-05-04 | - | X-dag bonusutdelning BIOG B 4.34 |
| 2017-05-03 | - | Årsstämma |
| 2017-05-03 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-10 | - | Bokslutskommuniké 2016 |
| 2016-10-25 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-17 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-11 | - | X-dag ordinarie utdelning BIOG B 3.03 SEK |
| 2016-05-11 | - | X-dag bonusutdelning BIOG B 1.97 |
| 2016-05-10 | - | Årsstämma |
| 2016-05-10 | - | Kvartalsrapport 2016-Q1 |
| 2016-03-18 | - | Extra Bolagsstämma 2016 |
| 2016-02-12 | - | Bokslutskommuniké 2015 |
| 2015-10-23 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-18 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-08 | - | X-dag ordinarie utdelning BIOG B 3.46 SEK |
| 2015-05-08 | - | X-dag bonusutdelning BIOG B 1.54 |
| 2015-05-07 | - | Årsstämma |
| 2015-05-07 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-12 | - | Bokslutskommuniké 2014 |
| 2014-10-22 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-20 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-07 | - | X-dag ordinarie utdelning BIOG B 3.35 SEK |
| 2014-05-07 | - | X-dag bonusutdelning BIOG B 3.65 |
| 2014-05-06 | - | Årsstämma |
| 2014-05-06 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-12 | - | Bokslutskommuniké 2013 |
| 2013-10-23 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-22 | - | Kvartalsrapport 2013-Q2 |
| 2013-04-29 | - | X-dag ordinarie utdelning BIOG B 4.15 SEK |
| 2013-04-29 | - | X-dag bonusutdelning BIOG B 5.85 |
| 2013-04-26 | - | Årsstämma |
| 2013-04-26 | - | Kvartalsrapport 2013-Q1 |
| 2013-04-26 | - | Analytiker möte 2013 |
| 2013-02-08 | - | Bokslutskommuniké 2012 |
| 2012-10-23 | - | Kvartalsrapport 2012-Q3 |
| 2012-10-23 | - | Analytiker möte 2012 |
| 2012-08-21 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-09 | - | X-dag ordinarie utdelning BIOG B 1.26 SEK |
| 2012-05-09 | - | X-dag bonusutdelning BIOG B 2.74 |
| 2012-05-08 | - | Årsstämma |
| 2012-05-08 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-10 | - | Bokslutskommuniké 2011 |
| 2011-11-17 | - | Kapitalmarknadsdag 2011 |
| 2011-10-25 | - | Kvartalsrapport 2011-Q3 |
| 2011-05-11 | - | X-dag ordinarie utdelning BIOG B 0.92 SEK |
| 2011-05-11 | - | X-dag bonusutdelning BIOG B 1.08 |
| 2011-05-10 | - | Årsstämma |
| 2011-05-10 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-11 | - | Bokslutskommuniké 2010 |
| 2010-10-27 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-17 | - | Kvartalsrapport 2010-Q2 |
| 2010-05-07 | - | X-dag ordinarie utdelning BIOG B 0.90 SEK |
| 2010-05-07 | - | X-dag bonusutdelning BIOG B 0.6 |
| 2010-05-06 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-22 | - | Bokslutskommuniké 2009 |
| 2009-10-22 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-18 | - | Kvartalsrapport 2009-Q2 |
| 2009-04-23 | - | X-dag ordinarie utdelning BIOG B 0.40 SEK |
| 2009-04-22 | - | Årsstämma |
| 2009-04-22 | - | Kvartalsrapport 2009-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
BioGaia announces that Theresa Agnew begins her role today, 25 September 2023, as the Chief Executive Officer of BioGaia.
As previously communicated, Theresa Agnew has 20-years of experience in various leadership roles within consumer healthcare, over-the-counter (OTC) drugs, and medical devices from leading companies such as GlaxoSmithKline (GSK), Essilor, and Johnson & Johnson.
Chairman of the Board, Peter Rothschild, commented, "We are pleased to welcome Theresa to BioGaia. We are confident that she possesses the right competence to lead BioGaia's future growth journey as a Swedish world-leading probiotics company. Theresa's entry marks an exciting new phase for BioGaia in our ongoing transformation to becoming both a Business-to-Business company and a Business-to-Consumer company."
Read more about Theresa Agnew in our previous press release: https://www.biogaia.com/pressrelease/biogaia-appoints-theresa-agnew-as-new-ceo/.
Follow us:
Subscribe to BioGaia press releases here (https://www.biogaia.com/press/subscribe-to-press-releases/)
LinkedIn here (https://www.linkedin.com/company/biogaia-ab/)
Contacts:
Peter Rothschild, Chairman of the Board
Email: pr@biogaia.se
Phone: +46 708 30 65 40
Mikaela Idermark Stern, Corporate Communications
Email: mis@biogaia.se
Phone: +46 730 95 61 50
About BioGaia
BioGaia is an innovative Swedish healthcare company that develops, markets, and sells probiotic products with documented health benefits. The products are sold through local distribution partners or via own-distribution in over 100 markets. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. biogaia.com (https://www.biogaia.com/)